US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,313.43

+22.351.73%

Number of Gainers:4

Number of Losers:3

Number of Flat:- -

PE:- -

High:1,314.86

Open:1,291.08

Low:1,273.99

Close:1,291.08

Loading ...

Novo Nordisk's obesity drug Wegovy debuts in Thailand

Eli Lily Shares Down 1.4% Premarket After HSBC Double Downgrades Rating to 'Reduce'

THOMSON REUTERS

Eli Lilly & Co : HSBC Cuts to Reduce From Buy

THOMSON REUTERS

Pfizer announces Phase 3 CREST trial met primary endpoint of EFS

1 Superstar Dividend Growth Stock to Buy if the Market Crashes

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in Bcg-NaÏVe, High-Risk Non-Muscle Invasive Bladder Cancer

THOMSON REUTERS

Pfizer Inc - Results Shared With Global Health Authorities for Regulatory Filings

THOMSON REUTERS

Pfizer Inc - Phase 3 Crest Trial Shows 32% Risk Reduction With Sasanlimab

THOMSON REUTERS

Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment

Simply Wall St.

Pfizer’s Stock Outlook: Analysts Weigh In on Future Prospects

Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts?

BRIEF-Amgen Announces $900 Mln Manufacturing Expansion, Creation Of 350 New Jobs In Ohio

AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO

Amgen Announces $900 Million Manufacturing Expansion, Creation of 350 New Jobs in Ohio

THOMSON REUTERS

Amgen Inc - Total Investment in Ohio to Exceed $1.4 Billion, 750 U.S. Jobs

THOMSON REUTERS

Why Novo Nordisk Stock Dropped Today

Lilly requests EMA to re-examine Alzheimer's drug recommendation

Ema Says Chmp Requested Re-Examination of Opinion Adopted for Marketing Authorisation Holder for Kisunla (Donanemab)

THOMSON REUTERS

Buy Healthcare Stocks Despite RFK Jr., Tariffs, and UnitedHealth -- Barrons.com

Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1313.4298,"timestamp":1745611199999,"preClose":1291.0822,"halted":0,"volume":54832112,"delay":0,"changeRate":0.017309,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":22.347656,"latestTime":"04-25 16:00:00 EDT","open":1291.0784,"high":1314.8612,"low":1273.9917,"amount":4955218948.609859,"amplitude":0.031655,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745847000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":10.07147,"peRate":35.219379,"turnoverRate":0.005191,"increases":4,"decrements":3,"flats":0,"marketCap":1399634233728,"floatMarketCap":1319082999424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1314.8612,"amplitude":0.031655,"preClose":1291.0822,"low":1273.9917,"pbRate":"10.07147","latestPrice":1313.4298,"volume":54832112,"delay":0,"open":1291.0784,"prevYearClose":1305.0607,"prevWeekClose":1313.4298,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1251.235,"twentyDayClose":1308.4729,"sixtyDayClose":1339.0923,"secType":"PLATE","market":"US","turnoverRate":0.005191,"peRate":35.219379,"marketCap":1399634233728,"floatMarketCap":1319082999424,"timestamp":1745611199999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":4,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530426773","title":"Novo Nordisk's obesity drug Wegovy debuts in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2530426773","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530426773?lang=en_us&edition=fundamental","pubTime":"2025-04-28 17:01","pubTimestamp":1745830913,"startTime":"0","endTime":"0","summary":"Novo Nordisk's obesity drug Wegovy debuts in ThailandBy Panu Wongcha-um","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R60IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","IE00BJT1NW94.SGD","LU1804176565.USD","SG9999015952.SGD","LU0882574055.USD","LU2471134952.CNY","LU0203202063.USD","LU2106854487.HKD","LU0456855351.SGD","LU1868836591.USD","LU2112291526.USD","SGXZ51526630.SGD","LU1868837136.USD","SG9999014914.USD","LU0203201768.USD","LU2461242641.AUD","LU0943347566.SGD","LU1988902786.USD","BK4581","LU1023059063.AUD","BK4007","BK4588","LU2237443549.SGD","LU2471134879.HKD","SG9999015978.USD","BK4534","IE00B2B36J28.USD","LU2491049909.HKD","SGXZ99366536.SGD","SG9999015986.USD","LU1551013342.USD","LU2264538146.SGD","LU0640476718.USD","LU0198837287.USD","LU1712237335.SGD","IE0004445239.USD","LU0097036916.USD","LU1069344957.HKD","LU1127390331.HKD","LU0672654240.SGD","LU1983299246.USD","BK4599","LU1623119135.USD","LU0823416689.USD","IE00BK4W5M84.HKD","LU2063271972.USD","LU0058720904.USD","LU0109391861.USD","LU2491050071.SGD"],"gpt_icon":1},{"id":"2530982423","title":"Eli Lily Shares Down 1.4% Premarket After HSBC Double Downgrades Rating to 'Reduce'","url":"https://stock-news.laohu8.com/highlight/detail?id=2530982423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530982423?lang=en_us&edition=fundamental","pubTime":"2025-04-28 16:37","pubTimestamp":1745829477,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4N3R60MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2750360641.GBP","LU0354030511.USD","LU0943347566.SGD","BK4599","LU0640476718.USD","LU2360106947.USD","LU1551013342.USD","LU2237443465.HKD","LU1720051108.HKD","LU0820561909.HKD","LU0096364046.USD","LU0820561818.USD","LU0203201768.USD","LU2023250504.SGD","LU2461242641.AUD","LU2552382132.HKD","LU1023059063.AUD","LU2468319806.SGD","LU1868836914.USD","SG9999001176.SGD","LU0471298777.SGD","LU1988902786.USD","LU0094547139.USD","LU2471134523.USD","LU0466842654.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1280957306.USD","IE00BK4W5L77.USD","LU1267930730.SGD","LU2357305700.SGD","LU2106854487.HKD","LU2211815571.USD","LU1720051017.SGD","LU0385154629.USD","LU1974910355.USD","SG9999014914.USD","BK4534","LU2471134952.CNY","LU2471134879.HKD","LU2237443895.HKD","LU1093756325.SGD","SGXZ31699556.SGD","SGXZ57979304.SGD","LLY","IE00BJT1NW94.SGD","SG9999015986.USD","LU1868836757.USD","LU1989771016.USD"],"gpt_icon":0},{"id":"2530414094","title":"Eli Lilly & Co  : HSBC Cuts to Reduce From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2530414094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530414094?lang=en_us&edition=fundamental","pubTime":"2025-04-28 13:21","pubTimestamp":1745817688,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nAZN3R5MUG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1366192091.USD","LU2750360997.AUD","LU0094547139.USD","LU0417517546.SGD","SG9999014914.USD","LU2089984988.USD","IE00BK4W5L77.USD","LU2361044949.HKD","LU0471298777.SGD","LU2750360641.GBP","LU2237443978.SGD","LU0289739699.SGD","LU0823416689.USD","BK4534","LU0820561818.USD","LU1804176565.USD","LU2237443549.SGD","LU0882574139.USD","LU0203202063.USD","LU1291159041.SGD","BK4585","LU1720051108.HKD","LU0466842654.USD","LU0689472784.USD","LU2112291526.USD","LU1551013342.USD","LU0354030511.USD","LLY","LU1868836914.USD","SG9999015986.USD","IE00B2B36J28.USD","BK4516","LU2211815571.USD","BK4599","LU1064131342.USD","LU2023250504.SGD","IE00BJLML261.HKD","LU0385154629.USD","LU1232071149.USD","LU2471134879.HKD","LU0456855351.SGD","LU0256863811.USD","LU1974910355.USD","IE00B4R5TH58.HKD","LU2237443895.HKD","LU2324357040.USD","LU2361045086.USD","BK4007","LU1267930730.SGD","LU2552382058.USD"],"gpt_icon":0},{"id":"2530466960","title":"Pfizer announces Phase 3 CREST trial met primary endpoint of EFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2530466960","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530466960?lang=en_us&edition=fundamental","pubTime":"2025-04-28 05:55","pubTimestamp":1745790914,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody, in combination...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-announces-phase-3-crest-trial-met-primary-endpoint-of-efs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-announces-phase-3-crest-trial-met-primary-endpoint-of-efs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225771236.USD","IE00B19Z3581.USD","SG9999013999.USD","LU0170899867.USD","LU1066051498.USD","LU0456855351.SGD","SG9999011175.SGD","BK4534","SG9999001176.USD","SG9999002232.USD","SG9999002224.SGD","LU1057294990.SGD","BK4588","LU1023059063.AUD","PFE","IE000M9KFDE8.USD","BK4007","BK4581","IE00BBT3K403.USD","LU0225284248.USD","IE0002270589.USD","SG9999001176.SGD","LU0306806265.USD","LU1894683348.USD","LU0321505439.SGD","LU0122379950.USD","LU0321505868.SGD","BK4568","BK4533","BK4599","LU0234572021.USD","LU1066053197.SGD","IE00BLSP4239.USD","LU0058720904.USD","LU0306807586.USD","LU1894683264.USD","SG9999003800.SGD","BK4592","LU1883839398.USD","BK4585","BK4550","IE00BLSP4452.SGD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","LU0289739699.SGD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2530642175","title":"1 Superstar Dividend Growth Stock to Buy if the Market Crashes","url":"https://stock-news.laohu8.com/highlight/detail?id=2530642175","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530642175?lang=en_us&edition=fundamental","pubTime":"2025-04-27 02:32","pubTimestamp":1745692320,"startTime":"0","endTime":"0","summary":"Investors have been waiting nearly a decade to score a good deal on this healthcare star.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/26/1-superstar-dividend-growth-stock-to-buy-if-the-ma/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00BBT3K403.USD","LU0306807586.USD","LU1066053197.SGD","LU1894683264.USD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4452.SGD","BK4568","IE000M9KFDE8.USD","BK4599","SG9999002232.USD","LU0321505439.SGD","BK4534","LU0170899867.USD","LU0321505868.SGD","LU0225771236.USD","LU1883839398.USD","LU0306806265.USD","IE0002270589.USD","SG9999001176.USD","LU0225284248.USD","BK4592","BK4007","BK4533","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999011175.SGD","LU1057294990.SGD","LU0868494617.USD","BK4588","SG9999003800.SGD","BK4585","IE00BLSP4239.USD","LU0122379950.USD","LU1894683348.USD","BK4581","SGXZ57979304.SGD","LU0456855351.SGD","LU0234572021.USD","LU0058720904.USD","LU0289739699.SGD","SG9999002224.SGD","SG9999001176.SGD","LU0985481810.HKD","BK4550","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2530178299","title":"Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in Bcg-NaÏVe, High-Risk Non-Muscle Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2530178299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530178299?lang=en_us&edition=fundamental","pubTime":"2025-04-27 01:30","pubTimestamp":1745688600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250426:nTUA4WRVS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0985481810.HKD","LU0234572021.USD","IE00BBT3K403.USD","BK4581","SG9999001176.SGD","LU1023059063.AUD","LU0058720904.USD","LU0225771236.USD","LU1894683264.USD","SG9999002224.SGD","LU1883839398.USD","SG9999002232.USD","SG9999011175.SGD","LU0289739699.SGD","BK4534","LU0306807586.USD","BK4550","LU1894683348.USD","LU0306806265.USD","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4585","SG9999013999.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","IE00BLSP4452.SGD","BK4533","LU1057294990.SGD","IE000M9KFDE8.USD","SG9999001176.USD","BK4599","LU0321505868.SGD","LU0868494617.USD","SGXZ57979304.SGD","LU1066053197.SGD","PFE","SG9999003800.SGD","BK4568","BK4592","IE00B19Z3581.USD","IE00BLSP4239.USD","IE0002270589.USD","LU0456855351.SGD","LU0225284248.USD","BK4007","BK4588"],"gpt_icon":0},{"id":"2530173628","title":"Pfizer Inc - Results Shared With Global Health Authorities for Regulatory Filings","url":"https://stock-news.laohu8.com/highlight/detail?id=2530173628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530173628?lang=en_us&edition=fundamental","pubTime":"2025-04-27 01:30","pubTimestamp":1745688600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250426:nTUA4WRVS7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BBT3K403.USD","LU0306807586.USD","BK4550","IE0002270589.USD","SG9999001176.USD","LU1894683264.USD","BK4599","LU1057294990.SGD","BK4568","SG9999013999.USD","BK4534","LU0170899867.USD","LU0122379950.USD","LU0225284248.USD","LU0306806265.USD","SG9999011175.SGD","PFE","BK4585","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0058720904.USD","LU0321505439.SGD","IE00B19Z3581.USD","BK4007","LU0321505868.SGD","LU1066053197.SGD","SG9999003800.SGD","BK4592","LU1883839398.USD","LU0289739699.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0234572021.USD","BK4533","IE00BLSP4239.USD","LU0456855351.SGD","BK4588","LU1023059063.AUD","LU0868494617.USD","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU1066051498.USD","LU0225771236.USD","LU1894683348.USD","IE000M9KFDE8.USD","BK4581"],"gpt_icon":0},{"id":"2530017364","title":"Pfizer Inc - Phase 3 Crest Trial Shows 32% Risk Reduction With Sasanlimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2530017364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530017364?lang=en_us&edition=fundamental","pubTime":"2025-04-27 01:30","pubTimestamp":1745688600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250426:nTUA4WRVS7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4007","LU0289739699.SGD","LU0306806265.USD","IE00BBT3K403.USD","BK4568","LU0234572021.USD","LU0306807586.USD","LU1894683348.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4581","IE0002270589.USD","BK4588","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0225284248.USD","LU0868494617.USD","LU1023059063.AUD","LU1894683264.USD","BK4550","SG9999002224.SGD","SG9999003800.SGD","BK4585","LU0122379950.USD","BK4599","SG9999011175.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0170899867.USD","BK4533","LU1883839398.USD","LU1066051498.USD","SG9999001176.SGD","PFE","LU0456855351.SGD","SG9999013999.USD","BK4592","LU1066053197.SGD","LU0225771236.USD","LU0321505868.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU1057294990.SGD","LU0321505439.SGD","SG9999001176.USD"],"gpt_icon":0},{"id":"2530173801","title":"Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2530173801","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530173801?lang=en_us&edition=fundamental","pubTime":"2025-04-27 01:16","pubTimestamp":1745687779,"startTime":"0","endTime":"0","summary":"Amgen recently announced a significant $900 million expansion in its Ohio manufacturing facility, aiming to strengthen its biomanufacturing capabilities. This investment is part of a strategic focus on enhancing U.S. manufacturing, alongside its $1 billion commitment to a new plant in North Carolina. Over the past quarter, Amgen's stock price moved by 2%, while the broader market increased by 8%. Although the company's investment plans signal long-term growth, this moderate movement in its share price suggests these developments added weight against broader market trends buoying returns.Every company has risks, and we've spotted 5 weaknesses for Amgen (of which 1 is a bit concerning!NasdaqGS:AMGN Earnings Per Share Growth as at Apr 2025. Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-nasdaqgs-amgn-expands-ohio-171619127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","LU1061106388.HKD","LU2242646821.SGD","IE00B2B36J28.USD","BK4588","BK4534","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","IE0009355771.USD","BK4566","BK4581","LU0122379950.USD","IE0002141913.USD","LU1571399168.USD","LU0058720904.USD","BK4599","LU1983299246.USD","LU2242652126.USD","BK4585","IE00B4R5TH58.HKD","LU1023059063.AUD","AMGN","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","SG9999001440.SGD","LU2089984988.USD","LU2468319806.SGD","LU2112291526.USD","LU0868494617.USD","BK4533","LU1057294990.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2530122074","title":"Pfizer’s Stock Outlook: Analysts Weigh In on Future Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2530122074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530122074?lang=en_us&edition=fundamental","pubTime":"2025-04-26 23:03","pubTimestamp":1745679830,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer (PFE) has been the focus of sev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizers-stock-outlook-analysts-weigh-in-on-future-prospects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizers-stock-outlook-analysts-weigh-in-on-future-prospects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505868.SGD","IE00B19Z3B42.SGD","BK4550","BK4581","LU0225771236.USD","LU0225284248.USD","BK4568","LU0058720904.USD","LU0170899867.USD","SGXZ57979304.SGD","BK4599","LU1057294990.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU1066053197.SGD","LU0306807586.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU1894683264.USD","LU0456855351.SGD","SG9999002232.USD","BK4585","LU1894683348.USD","SG9999003800.SGD","SG9999001176.SGD","LU0985481810.HKD","LU0289739699.SGD","BK4534","BK4592","PFE","SG9999002224.SGD","LU0868494617.USD","BK4533","SG9999001176.USD","LU0306806265.USD","IE0002270589.USD","IE00BLSP4452.SGD","BK4007","BK4588","SG9999011175.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU0122379950.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU1066051498.USD","SG9999013999.USD"],"gpt_icon":0},{"id":"2530199527","title":"Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530199527","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530199527?lang=en_us&edition=fundamental","pubTime":"2025-04-26 04:31","pubTimestamp":1745613110,"startTime":"0","endTime":"0","summary":"We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going to take a look at where Structure Therapeutics Inc.  stands against other promising small-cap stocks.Robert Teeter of Silvercrest Asset Management recently appeared in an interview to express that he thinks small-cap stocks are currently facing a choppy market, but he also acknowledged that he anticipates a rally later in the year. Based on this sentiment, he advised clients on the importance of diversification within the S&P 500 and pointed to opportunities in international markets. We covered his stance in greater detail in one of our other articles,10 Best Small-Cap Value Stocks to Buy Now. Here’s an excerpt from it:. Why are we interested in the stocks that hedge funds pile into?The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/structure-therapeutics-inc-nasdaq-gpcr-203150034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VOO","SPY","SDS","TQQQ","QID","BK4504","IE00B64PRP62.GBP","SSO","NVIW.SI","NQmain","PSQ","GPCR",".IXIC","SQQQ","BK4581","USAW.SI","BK4585","OEF","MNQmain","QLD","LU2210150020.SGD","USJW.SI","BK4007","BK4559","IE00BKPKM429.USD",".SPX","BK4599","LU2210149790.SGD","BK4534","SPXU","BK4588","IE00B3QW5Z07.USD","ESmain","BK4112","LU2095319765.USD","BK4550","IVV","NDAQ","TSYW.SI","SH","OEX","IE00BGHQF748.EUR"],"gpt_icon":1},{"id":"2530164863","title":"BRIEF-Amgen Announces $900 Mln Manufacturing Expansion, Creation Of 350 New Jobs In Ohio","url":"https://stock-news.laohu8.com/highlight/detail?id=2530164863","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530164863?lang=en_us&edition=fundamental","pubTime":"2025-04-26 03:20","pubTimestamp":1745608855,"startTime":"0","endTime":"0","summary":"BRIEF-Amgen Announces $900 Mln Manufacturing Expansion, Creation Of 350 New Jobs In OhioApril 25  - Amgen Inc AMGN.O:AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIOAMGEN INC - TOTAL INVESTMENT IN OHIO TO EXCEED $1.4 BILLION, 750 U.S. JOBSFurther company coverage: AMGN.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R326M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0122379950.USD","AMGN","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4585","LU2242646821.SGD","IE0009355771.USD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4533","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1983299246.USD","BK4139","LU0109394709.USD","LU1571399168.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","BK4534","BK4566","LU2242652126.USD","BK4599","BK4581","LU0058720904.USD","LU2468319806.SGD","LU0868494617.USD","LU2112291526.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2530150537","title":"AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO","url":"https://stock-news.laohu8.com/highlight/detail?id=2530150537","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530150537?lang=en_us&edition=fundamental","pubTime":"2025-04-26 00:47","pubTimestamp":1745599620,"startTime":"0","endTime":"0","summary":"Total Investment in the State to Exceed $1.4 Billion, 750 U.S. Jobs. THOUSAND OAKS, Calif., April 25, 2025 /PRNewswire/ -- Amgen  today announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number of jobs created to 750 and the total investment in Central Ohio to over $1.4 billion.\"Amgen has been a leading U.S.-based manufacturer of biologic medicines since 1988. Today's investment reinforces our ongoing commitment to expanding U.S. manufacturing and ensuring patients around the world have access to our innovative medicines,\" said Robert A. Bradway, chairman and chief executive officer atAmgen.\"Ohio offers a supportive business climate, skilled workforce, and strategic location, making it an ideal choice for this next phase of our investment.\". In 2024, Amgen was named one of the \"World's Most Innovative Companies\" by Fast Company and one of \"America's Best Large Employers\" by Forbes, among otherexternal recognitions. Amgen is one of the 30 companies","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/amgen-announces-900-million-manufacturing-164700052.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-announces-900-million-manufacturing-164700052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2242646821.SGD","IE00B2B36J28.USD","LU2112291526.USD","LU2242652126.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","JOBS","LU1057294990.SGD","LU0058720904.USD","LU0889565916.HKD","LU0868494617.USD","IE0002141913.USD","BK4566","BK4534","LU1983299246.USD","BK4588","BK4531","BK4130","BK4599","LU2089984988.USD","LU0289739699.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","BK4581","BK4585","IE0009355771.USD","BK4533","IE00B4R5TH58.HKD","AMGN","LU1023059063.AUD","LU1061106388.HKD","BK4139","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","LU0109394709.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2530157929","title":"Amgen Announces $900 Million Manufacturing Expansion, Creation of 350 New Jobs in Ohio","url":"https://stock-news.laohu8.com/highlight/detail?id=2530157929","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530157929?lang=en_us&edition=fundamental","pubTime":"2025-04-26 00:45","pubTimestamp":1745599534,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R326M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1571399168.USD","LU1061106388.HKD","BK4581","LU0320765992.SGD","LU2089984988.USD","LU1023059063.AUD","LU0058720904.USD","LU2468319806.SGD","LU2242652126.USD","SG9999001440.SGD","LU0289739699.SGD","BK4534","IE00BFTCPJ56.SGD","BK4139","BK4585","IE0002141913.USD","LU0122379950.USD","BK4566","LU2112291526.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","BK4533","LU1057294990.SGD","IE00B2B36J28.USD","BK4599","LU0889565916.HKD","LU0868494617.USD","LU0109394709.USD","LU2242646821.SGD","AMGN","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588"],"gpt_icon":0},{"id":"2530157901","title":"Amgen Inc - Total Investment in Ohio to Exceed $1.4 Billion, 750 U.S. Jobs","url":"https://stock-news.laohu8.com/highlight/detail?id=2530157901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530157901?lang=en_us&edition=fundamental","pubTime":"2025-04-26 00:45","pubTimestamp":1745599534,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R326M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE0002141913.USD","LU2089984988.USD","LU1057294990.SGD","BK4599","BK4566","LU0889565916.HKD","BK4581","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4534","LU0868494617.USD","LU1571399168.USD","BK4533","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0058720904.USD","IE00BFTCPJ56.SGD","BK4585","SG9999001440.SGD","LU2242646821.SGD","IE0009355771.USD","LU2242652126.USD","LU1983299246.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU0109394709.USD","BK4588","LU0320765992.SGD","LU2112291526.USD","LU1061106388.HKD","AMGN"],"gpt_icon":0},{"id":"2530153877","title":"Why Novo Nordisk Stock Dropped Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2530153877","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530153877?lang=en_us&edition=fundamental","pubTime":"2025-04-25 22:58","pubTimestamp":1745593080,"startTime":"0","endTime":"0","summary":"Ignore the noise. Novo Nordisk stock is a bargain.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/25/why-novo-nordisk-stock-dropped-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4588","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","LU0154236417.USD","NVO","BK4532","BK4585","BK4007"],"gpt_icon":1},{"id":"2530313770","title":"Lilly requests EMA to re-examine Alzheimer's drug recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2530313770","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530313770?lang=en_us&edition=fundamental","pubTime":"2025-04-25 22:29","pubTimestamp":1745591395,"startTime":"0","endTime":"0","summary":"UPDATE 1-Lilly requests EMA to re-examine Alzheimer's drug recommendationAdds details in paragraphs 3, 4 and 5. April 25  - Eli Lilly LLY.N has requested Europe's medicines regulator to re-examine its opinion on the company's Alzheimer's drug, the agency said on Friday. Last month, the regulator had rejected the drug, Kisunla, saying that the treatment's ability to slow cognitive decline was not large enough to outweigh the risk of serious brain swelling in patients.Lilly had said at the time that it planned to seek a re-examination from the regulator. Upon receiving the grounds of the request, the agency said it will reconsider its opinion and issue a final recommendation for the drug. Lilly's drug is already approved in the United States.   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4N3R31IB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU0354030511.USD","LU0198837287.USD","LU1868836591.USD","LU2237443465.HKD","LU0256863811.USD","LU2237443382.USD","LU2602419157.SGD","LU1280957306.USD","LU0203202063.USD","LLY","LU2471134523.USD","BK4599","LU1093756168.USD","SG9999014898.SGD","LU2361044865.SGD","LU0882574139.USD","LU1989771016.USD","SG9999015986.USD","LU0114720955.EUR","LU0289739699.SGD","LU0320765059.SGD","LU1623119135.USD","LU0061475181.USD","LU1720051108.HKD","BK4533","LU0456855351.SGD","LU1232071149.USD","LU1868837300.USD","LU2106854487.HKD","LU2211815571.USD","LU0882574055.USD","IE0009355771.USD","LU2360106947.USD","LU2552382215.SGD","SG9999015945.SGD","LU2357305700.SGD","SG9999018865.SGD","LU2264538146.SGD","SGXZ81514606.USD","LU1064131342.USD","LU0689472784.USD","LU0471298694.HKD","LU2237443895.HKD","SG9999014906.USD","SG9999015978.USD","LU0109391861.USD","LU0106261372.USD","BK4581","LU1127390331.HKD"],"gpt_icon":1},{"id":"2530565134","title":"Ema Says Chmp Requested Re-Examination of Opinion Adopted for Marketing Authorisation Holder for Kisunla (Donanemab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530565134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530565134?lang=en_us&edition=fundamental","pubTime":"2025-04-25 22:00","pubTimestamp":1745589645,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R3266:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0466842654.USD","BK4585","LU1093756325.SGD","LU2357305700.SGD","LU0417517546.SGD","LU0471298777.SGD","LU2491050071.SGD","LU2063271972.USD","LU2106854487.HKD","LU0882574139.USD","LU2265009873.SGD","LU0006306889.USD","SG9999014906.USD","LU0823416689.USD","IE00B4R5TH58.HKD","IE00BJLML261.HKD","BK4007","BK4533","LU1069344957.HKD","LU0708995401.HKD","LU1232071149.USD","LLY","LU1989771016.USD","IE0002141913.USD","LU0471298694.HKD","LU0238689110.USD","LU2324357040.USD","IE00B2B36J28.USD","LU0672654240.SGD","LU1127390331.HKD","LU0256863811.USD","LU1548497426.USD","BK4599","LU2264538146.SGD","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU2750360641.GBP","LU1804176565.USD","LU1280957306.USD","LU2237443622.USD","SG9999014898.SGD","LU1868837136.USD","SG9999014880.SGD","IE0009355771.USD","LU2552382058.USD","IE00BK4W5L77.USD","LU2237443978.SGD","LU0820561818.USD","LU2750360997.AUD"],"gpt_icon":0},{"id":"2530264929","title":"Buy Healthcare Stocks Despite RFK Jr., Tariffs, and UnitedHealth -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2530264929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530264929?lang=en_us&edition=fundamental","pubTime":"2025-04-25 14:00","pubTimestamp":1745560800,"startTime":"0","endTime":"0","summary":"You'd think that the healthcare sector would be one of the worst performers in the market this year due to worries about Health and Human Services Secretary Robert F. Kennedy Jr. and the terrible earnings guidance from insurer UnitedHealth Group. But the sector is more than holding its own in 2025.The Health Care Select Sector SPDR exchange-traded fund  is flat this year while the broader market is down. Tariffs and trade war worries are less of a concern, given the domestic focus of many companies in the industry. And investors also seem to appreciate that many of the companies in the group are relatively recession-resistant.\"People are going to keep getting sick, pay their insurance premiums and see their doctor,\" Jonathan Curtis, chief investment officer at Franklin Equity Group, said at a recent media event. \"This is a defensive sector.\". \"While insiders are generally not 'precision market timers,' they are rarely wrong 1-3 years later,\" Kaeppel writes. \"All of this strongly sugges","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","UNH","LU0097036916.USD","LU0976567544.SGD","OEF","IE00B4JS1V06.HKD","SH","LU1914381329.SGD","LU0708994859.HKD","SG9999001440.SGD","CI","AMGN","LU1003077747.HKD","LU0342679015.USD","LU0943347566.SGD","LU1720051017.SGD","OEX","SG9999014914.USD","IE00BWXC8680.SGD","LU1037948541.HKD","SPXU","LU0820562030.AUD","LU2491049909.HKD","LU2471134523.USD","VOO","LU1791710582.SGD","LU0048584097.USD","LU2362540622.SGD","ESmain","LU1323610961.USD","CVS","LU1057294990.SGD","SDS","IE00BJT1NW94.SGD","SG9999015986.USD","SPY","SSO","BK4532","LU1868837300.USD","LU1064131342.USD","LU0070302665.USD","BK4599",".SPX","IE00B894F039.SGD","IE00BJLML261.HKD","IE00BJJMRY28.SGD","HCSG","IVV"],"gpt_icon":1},{"id":"2530964139","title":"Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2530964139","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530964139?lang=en_us&edition=fundamental","pubTime":"2025-04-25 03:36","pubTimestamp":1745523394,"startTime":"0","endTime":"0","summary":"Guardant Health, Inc. on Thursday announced a strategic collaboration with Pfizer, Inc.  to support the development and commercialization of Pfizer’s oncology portfolio using the Guardant Infinity smart liquid biopsy platform.Under the multi-year collaboration agreement, Guardant and Pfizer aim to:. Utilize Guardant’s portfolio of liquid biopsy tests in Pfizer’s global clinical studies.Evaluate the clinical utility of  circulating tumor DNA  level as a surrogate endpoint to monitor therapy response and  related blood-based epigenomic analyses.Also Read: Medicare To Reimburse Guardant Health’s Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue. The collaboration will also allow Pfizer to access Guardant’s liquid biopsy tests in China for its global clinical trials, which include China cohorts.Guardant Reveal, which runs on Guardant’s Smart Liquid Biopsy platform, is a blood test that uses epigenomic  analysis to detect circulating tumor DNA , a marker of minimal residual dis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/guardant-health-pfizer-collaborate-develop-193634667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","LU0868494617.USD","LU0225771236.USD","BK4585","LU0234572021.USD","BK4213","BK4196","LU0321505868.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","LU0170899867.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4007","BK4533","LU0306806265.USD","LU1023059063.AUD","SG9999011175.SGD","CRC","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU1066053197.SGD","LU0122379950.USD","LU0266512127.USD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU0456854461.SGD","IE0002270589.USD","SG9999002224.SGD","SG9999001176.USD","LU0289739699.SGD","LU1883839398.USD","SG9999003800.SGD","BK4599","BK4550","GH","BK4551","BK4588","LU0456855351.SGD","BK4581","PFE","LU1066051498.USD","LU0321505439.SGD","LU1894683348.USD","BK4534","LU1057294990.SGD","SG9999002232.USD","LU0225284248.USD","SG9999001176.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":171,"code":"91000000","status":"200"}]}}